Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001161697-21-000383)

Filing Details

Accession Number:: 0001161697-21-000383
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-08-17 16:48:59
Reporting Period:: 2021-08-13

Accepted Time:: 2021-08-17 16:48:59
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1369568	Catalyst Pharmaceuticals Inc.	CPRX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1292636	S David Tierney	355 Alhambra Circle, Suite 801 Coral Gables FL 33134		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.001 Per Share	Acquisiton	2021-08-13	50,000	$3.12	356,874	No	4	M	Direct
Common Stock, Par Value $0.001 Per Share	Disposition	2021-08-13	50,000	$6.08	306,874	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Options to purchase common stock	Disposition	2021-08-13	50,000	$0.00	50,000	$3.12

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
306,167		2021-08-28	No	4	M	Direct

Footnotes

Dr. Tierney has advised the Company that the sale of shares was to raise funds for personal reasons and does not relate to any disagreements with the Company on any matter relating to the Company's operations, policies or practices. Dr. Tierney remains a Director of the Company.
The option was granted on August 28, 2014 and previously vested in two equal annual installments.